Technology Segment Analysis: Flow Measurement (Largest Segment) vs Peak Flow Meters (Fastest-Growing Segment)

In the spirometer market, flow measurement technology accounted for the largest share of 64.7% in 2026, reflecting its broad applicability in pulmonary function assessment. Flow measurement systems are widely used to evaluate airflow patterns and respiratory performance, making them an important component of routine diagnosis and monitoring for patients with respiratory disorders. Their established use across hospitals, clinics, diagnostic laboratories, and other healthcare environments supports sustained demand, particularly as pulmonary function testing becomes increasingly important for identifying and managing chronic respiratory conditions. At the same time, the peak flow meters segment is experiencing the fastest growth as respiratory monitoring moves beyond conventional clinical environments toward more convenient and patient-centered assessment. Peak flow meters offer a practical approach for tracking changes in airway function and can support regular monitoring by patients and healthcare professionals. Their usefulness in asthma management, particularly for observing variations in airflow and supporting treatment decisions, contributes to growing adoption. The increasing emphasis on home-based monitoring and self-management of respiratory conditions is further creating favorable conditions for this segment.

Application Segment Analysis: COPD (Largest Segment) vs Asthma (Fastest-Growing Segment)

COPD dominated the spirometer market with a 42.4% share in 2026, supported by the importance of pulmonary function testing in diagnosing, staging, and monitoring chronic obstructive respiratory disease. Spirometry is central to assessing airflow limitation in COPD and provides clinicians with objective information that can assist in evaluating disease progression and treatment response. The growing focus on early recognition and continuous management of chronic respiratory conditions sustains demand for spirometry-based assessment among healthcare providers. In contrast, the asthma application segment is advancing at the fastest pace, driven by the need for ongoing respiratory monitoring and improved management of variable airway obstruction. Asthma care increasingly emphasizes regular assessment of lung function alongside symptom tracking, creating opportunities for spirometry and related respiratory measurement technologies. Greater awareness of asthma management, increased attention to personalized treatment, and the expansion of monitoring outside traditional hospital environments are supporting adoption. The ability to use respiratory measurements as part of ongoing disease management further strengthens the growth prospects of the asthma segment.